Skip to main content
Premium Trial:

Request an Annual Quote

GenapSys: Jason Myers, Hesaam Esfandyarpour

GenapSys has named Jason Myers CEO, effective Feb. 15, 2021, replacing founder Hesaam Esfandyarpour. Myers will also join the board of directors. 

Myers comes to GenapSys from Invitae, where he was president of oncology. Prior to that, he was president and CEO of ArcherDx, which he also cofounded, until Invitae acquired the company last October. He also previously held positions at Ion Torrent, and holds a doctorate molecular pharmacology from Stanford University. Myers will continue to serve on Invitae's board of directors.

Esfandyarpour, who served as CEO since 2010, will remain as GenapSys' chairman. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.